A detailed history of Compass Rose Asset Management, LP transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Compass Rose Asset Management, LP holds 600,000 shares of BHC stock, worth $2.92 Million. This represents 1.21% of its overall portfolio holdings.

Number of Shares
600,000
Previous 2,100,000 71.43%
Holding current value
$2.92 Million
Previous $16.9 Billion 77.06%
% of portfolio
1.21%
Previous 6.77%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025

SELL
$6.16 - $7.94 $9.24 Million - $11.9 Million
-1,500,000 Reduced 71.43%
600,000 $3.88 Billion
Q4 2024

Feb 14, 2025

BUY
$7.34 - $9.78 $12.1 Million - $16.1 Million
1,650,000 Added 366.67%
2,100,000 $16.9 Billion
Q3 2024

Nov 14, 2024

BUY
$5.22 - $8.26 $2.35 Million - $3.72 Million
450,000 New
450,000 $3.67 Billion

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $1.76B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Compass Rose Asset Management, LP Portfolio

Follow Compass Rose Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Compass Rose Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Compass Rose Asset Management, LP with notifications on news.